EFFECT OF BETA-BLOCKERS ON BONE MINERAL DENSITY AND OSTEOPOROTIC FRACTURES

EFFECT OF BETA-BLOCKERS ON BONE MINERAL DENSITY AND OSTEOPOROTIC FRACTURES

This review presents the current data on the pleiotropic effects of beta-blockers in particular on the effect on bone mass and fracture development by means of increased bone fragility. In this article we discuss the mechanisms of action of beta-blockers on bone metabolism and their possible protect...

Full description

Bibliographic Details
Main Authors:	K E Sobchenko, I A Skripnikova, E S Abirova, P A Ptichkina
Format:	Article
Language:	English
Published:	Endocrinology Research Centre 2013-12-01
Series:	Остеопороз и остеопатии
Subjects:	бета-адреноблокаторы остеопороз остеопоротические переломы
Online Access:	https://endojournals.ru/index.php/osteo/article/view/8847

Similar Items

EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS
by: I. A. Skripnikova, et al.
Published: (2015-12-01)

PREVALENCE AND RISK FACTORS OF LOW-ENERGY SKELETAL FRACTURES IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES. THE RESULTS OF A MULTICENTER STUDY OF THE RUSSIAN ASSOCIATION ON OSTEOPOROSIS GLUKOST
by: I A Baranova, et al.
Published: (2014-12-01)

Analysis of epidemiology of osteoporotic fracturesusing data from primary care physicians
by: E. N. Gladkova, et al.
Published: (2011-04-01)

USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?
by: V. V. Samoylenko, et al.
Published: (2015-09-01)

ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT?
by: S. Y. Martsevich
Published: (2016-01-01)

IZUChENIE PLEYOTROPNYKh EFFEKTOV V-ADRENOBLOKATOROV I INGIBITOROV APF NA KOSTNUYu TKAN'
by: I A SKRIPNIKOVA, et al.
Published: (2014-12-01)

Contribution of age and functional disorders into the formation of vitamin D deficiency
by: I. S. Dydykina, et al.
Published: (2016-12-01)

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE
by: M. V. Leonova
Published: (2015-12-01)

Lung function dynamics in smoking and non-smoking patients with stable effort angina, treated with beta-adrenoblockers
by: Yu. V. Lukina, et al.
Published: (2004-04-01)

THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS?
by: A. N. Sumin
Published: (2015-09-01)

ZOLEDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS AND OTHER SKELETAL DISORDERS
by: S Yu Vorotnikova, et al.
Published: (2016-12-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
by: O. D. Ostroumova, et al.
Published: (2015-12-01)

PRIMENENIE TERIPARATIDA DLYa LEChENIYa TYaZhELOGO OSTEOPOROZA S MNOZhESTVENNYMI PERELOMAMI
by: E A PIGAROVA, et al.
Published: (2014-12-01)

Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa
by: E G Volkova
Published: (2005-06-01)

Iatrogenic lesions of the skeleton
by: Galina A. Melnichenko, et al.
Published: (2016-07-01)

OSTEOPOROSIS AND ASSOCIATED FRACTURES IN OLDER PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
by: E N Gladkov, et al.
Published: (2015-12-01)

TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE
by: O. V. Gaisenok, et al.
Published: (2015-09-01)

Fragility fractures and bone remodeling in type 2 diabetes mellitus
by: Tatiana O. Yalochkina, et al.
Published: (2017-11-01)

PROLIA (DENOSUMAB): ANALYSIS OF RECENT PUBLICATIONS FROM THE AMERICAN SOCIETY FOR BONE AND MINERAL RESEARCH (ASMBR) MEETING 2013
by: E A Pigarova
Published: (2013-12-01)

COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL
by: S. Y. Martsevich, et al.
Published: (2016-01-01)

POSSIBILITIES AND PROSPECTS OF DOUBLE EFFECT DRUGS APPLICATION FOR SYSTEMIC OSTEOPOROSIS PHARMACOTHERAPY OF PATIENTS WITH BONE FRACTURES
by: A. Y. Kochish, et al.
Published: (2012-06-01)

Diabetes and consolidation of fractures
Published: (2013-06-01)

MODERN VIEW ON THE EFFECTIVENESS OF THERAPY FOR POSTMENOPAUSAL OSTEOPOROSIS. INNOVATIVE DRUGS OF TARGETED ACTION
by: N G Mokrysheva, et al.
Published: (2013-12-01)

ATYPICAL FRACTURES DUE TO LONG TREATMENT WITH BISPHOSPHONATES (CRITICAL REVIEW)
by: G. S. Golubev
Published: (2013-03-01)

Metoprolol tartrate. Сlinical use
by: A. A. Zateischikova
Published: (2015-12-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

THE RUSSIAN COUNCIL OF ExPERTS FOR IMPROVEMENT THE APPROACHES TO THE TREATMENT OF OSTEOPOROSIS
by: A A Volna, et al.
Published: (2015-12-01)

The place of metoprolol tartrate in the treatment of cardiovascular diseases
by: N. V. Romanova, et al.
Published: (2016-12-01)

COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2)
by: S. Y. Martsevich, et al.
Published: (2015-12-01)

TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2)
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

ORIGINAL ARTICLES CLINICAL AND PROGNOSTIC SIGNIFICANCE OF MOLECULAR GENETIC FACTORS IN POSTMENOPAUSAL OSTEOPOROSIS
by: S V Yureneva, et al.
Published: (2015-12-01)

EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE
by: I. V. Vologdina
Published: (2015-12-01)

DRUGS AND SMOKING
by: J. V. Lukina
Published: (2015-12-01)

THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS
by: M. A. Maksimova, et al.
Published: (2015-09-01)

CLINICAL AND INSTRUMENTAL CHARACTERISTICS OF REPEATED OSTEOPOROTIC FRACTURES IN PATIENTS OF GOMEL REGION OF BELORUSSIA AND MODERN THERAPEUTIC STRATEGY
by: G N Romanov, et al.
Published: (2014-12-01)

Whether to prescribe calcium and vitamin D: arguments pro and contra
by: N. V. Toroptsova
Published: (2013-12-01)

Interrelation of bone mineral density with kneeosteoarthrosis
by: E. M. Zaytseva, et al.
Published: (2011-04-01)

THE RELATIONSHIP OF THE DISTAL DIABETIC POLYNEUROPATHY WITH PARAMETERS OF FOOT BONE MINERAL DENSITY IN PATIENTS WITH DIABETES MELLITUS
by: N A Molitvoslovova, et al.
Published: (2013-12-01)

THE INFLUENCE OF INFLIXIMAB THERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS
by: T A Raskina, et al.
Published: (2013-12-01)